...
首页> 外文期刊>Archives of gynecology and obstetrics. >The role of HPV DNA testing in the follow-up of cervical intraepithelial neoplasia after loop electrosurgical excision procedure.
【24h】

The role of HPV DNA testing in the follow-up of cervical intraepithelial neoplasia after loop electrosurgical excision procedure.

机译:HPV DNA检测在回路电外科切除术后宫颈上皮内瘤变的随访中的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: To assess human papilloma viruses (HPV) DNA test for detection of recurrences in cervical intraepithelial neoplasia (CIN) patients after loop electrosurgical excision procedure (LEEP). Also effect of LEEP on the clearance of HPV infection was evaluated for CIN 1 lesions. METHODS: HPV DNA positive 37 patients (25 CIN 2-3 and 12 CIN 1 cases proven by colposcopic biopsies) were treated with LEEP and followed prospectively with HPV DNA and cytology at third and sixth months. RESULTS: There were 11 patients with abnormal cytologic results in third month and 4 in sixth month. HPV DNA positivity rate declined in CIN 1 group between third and sixth month but this did not reach to statistical significance (44 vs. 36%, P = 0.41). There were 3 treatment failures out of 37 patients (8.1%). All these three patients had CIN 3 at the beginning and two of them had positive HPV DNA in two controls. There were no recurrence/treatment failure for CIN 1 patients. Regarding 37 patients, decrease in cytologic abnormality incidence between third and sixth-month control was statistically significant (29.7 vs. 10.9%, P = 0.03). All four patients with cytologic abnormality at the sixth month had HPV persistence. Cytologic abnormality was more prevelant in HPV persistent women (P = 0.01) and also there was no cytologic abnormality in case of HPV DNA negativity. CONCLUSION: LEEP does not seem to decrease HPV DNA incidence for CIN 1 at least for 6 months. But HPV DNA used in addition to cytology might help to detect recurrences.
机译:目的:评估人乳头瘤病毒(HPV)DNA检测在环行电外科手术切除(LEEP)后宫颈上皮内瘤变(CIN)患者中的复发检测。还针对CIN 1病变评估了LEEP对清除HPV感染的作用。方法:对37例HPV DNA阳性的患者(经阴道镜活检证实为25 CIN 2-3和12 CIN 1例)进行了LEEP治疗,并在第三和第六个月进行了HPV DNA和细胞学检查。结果:第三个月有11例细胞学结果异常,第六个月有4例。 CIN 1组的HPV DNA阳性率在第三个月到第六个月之间下降,但是没有达到统计学显着性(44比36%,P = 0.41)。 37例患者中有3例治疗失败(8.1%)。所有这三名患者开始时都具有CIN 3,其中两名在两个对照组中HPV DNA阳性。 CIN 1患者没有复发/治疗失败。在37例患者中,第三个月和第六个月对照组之间细胞学异常发生率的降低具有统计学意义(29.7比10.9%,P = 0.03)。在第四个月所有四例细胞学异常的患者均具有HPV持续性。在HPV持续存在的女性中,细胞学异常更为普遍(P = 0.01),并且在HPV DNA阴性的情况下也没有细胞学异常。结论:LEEP似乎并没有降低CIN 1的HPV DNA发生率至少持续6个月。但是,除了细胞学检查外,还可以使用HPV DNA来检测复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号